Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 363

1.

Trends of Cardiac Complications in Patients With Rheumatoid Arthritis: Analysis of the United States National Inpatient Sample; 2005-2014.

Bandyopadhyay D, Banerjee U, Hajra A, Chakraborty S, Amgai B, Ghosh RK, Haddadin FI, Modi VA, Sinha K, Aronow WS, Deedwania P, Lavie CJ.

Curr Probl Cardiol. 2019 Aug 23:100455. doi: 10.1016/j.cpcardiol.2019.100455. [Epub ahead of print] Review.

PMID:
31526517
2.

Emerging strategies for diabetes and cardiovascular disorders: Introduction and foreword.

Deedwania P.

Prog Cardiovasc Dis. 2019 Aug 27. pii: S0033-0620(19)30109-4. doi: 10.1016/j.pcad.2019.08.005. [Epub ahead of print] No abstract available.

PMID:
31469996
3.

An update on pharmacotherapies in diabetic dyslipidemia.

Gupta M, Tummala R, Ghosh RK, Blumenthal C, Philip K, Bandyopadhyay D, Ventura H, Deedwania P.

Prog Cardiovasc Dis. 2019 Aug 20. pii: S0033-0620(19)30105-7. doi: 10.1016/j.pcad.2019.07.006. [Epub ahead of print] Review.

PMID:
31442512
4.

Cardiovascular outcome trials of the newer anti-diabetic medications.

Acharya T, Deedwania P.

Prog Cardiovasc Dis. 2019 Aug 21. pii: S0033-0620(19)30106-9. doi: 10.1016/j.pcad.2019.08.003. [Epub ahead of print] Review.

PMID:
31442511
5.

Oral insulin: an update.

Chatterjee S, Sharma CB, Lavie CJ, Adhikari A, Deedwania P, O'keefe JH.

Minerva Endocrinol. 2019 Jul 24. doi: 10.23736/S0391-1977.19.03055-4. [Epub ahead of print]

PMID:
31347343
6.

Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials.

Ferdinand KC, Jacobson TA, Koren A, Elassal J, Thompson D, Deedwania P.

J Clin Lipidol. 2019 Jul - Aug;13(4):586-593.e5. doi: 10.1016/j.jacl.2019.06.002. Epub 2019 Jun 27.

7.

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.

Charytan DM, Sabatine MS, Pedersen TR, Im K, Park JG, Pineda AL, Wasserman SM, Deedwania P, Olsson AG, Sever PS, Keech AC, Giugliano RP; FOURIER Steering Committee and Investigators.

J Am Coll Cardiol. 2019 Jun 18;73(23):2961-2970. doi: 10.1016/j.jacc.2019.03.513. Erratum in: J Am Coll Cardiol. 2019 Aug 27;74(8):1162-1166.

PMID:
31196453
8.

Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America.

Vijayaraghavan K, McCullough PA, Singh B, Gupta M, Enas E, Mohan V, Misra A, Deedwania P, Brinton EA; for the Consensus Panel Steering Committee .

Cardiorenal Med. 2019;9(4):240-251. doi: 10.1159/000499341. Epub 2019 May 10.

9.

Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies.

Tummala R, Ghosh RK, Jain V, Devanabanda AR, Bandyopadhyay D, Deedwania P, Aronow WS.

Am J Med. 2019 May 8. pii: S0002-9343(19)30392-4. doi: 10.1016/j.amjmed.2019.04.027. [Epub ahead of print] Review.

PMID:
31077653
10.

Cardiovascular Protection with Anti-hyperglycemic Agents.

Deedwania P, Acharya T.

Am J Cardiovasc Drugs. 2019 Jun;19(3):249-257. doi: 10.1007/s40256-019-00325-9. Review.

PMID:
30767126
11.

25-Year trends in hypertension prevalence, awareness, treatment, and control in an Indian urban population: Jaipur Heart Watch.

Gupta R, Gupta VP, Prakash H, Agrawal A, Sharma KK, Deedwania PC.

Indian Heart J. 2018 Nov - Dec;70(6):802-807. doi: 10.1016/j.ihj.2017.11.011. Epub 2017 Nov 13.

12.

The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery Disease.

Deedwania P.

J Am Heart Assoc. 2018 Oct 16;7(20):e010752. doi: 10.1161/JAHA.118.010752.

13.

American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations.

Sasson C, Eckel R, Alger H, Bozkurt B, Carson A, Daviglus M, Deedwania P, Kirley K, Lamendola C, Nguyen M, Rajgopal Singh R, Wang T, Sanchez E.

J Am Heart Assoc. 2018 Aug 7;7(15):e009271. doi: 10.1161/JAHA.118.009271. No abstract available.

14.

Dangers of Hypoglycemia in Cardiac Patients With Diabetes: Time to Switch to Safer, Newer Drugs.

Deedwania P.

J Am Coll Cardiol. 2018 Oct 9;72(15):1787-1789. doi: 10.1016/j.jacc.2018.08.2138. No abstract available.

PMID:
30286921
15.

SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality?

Chatterjee S, Bandyopadhyay D, Ghosh RK, Majumdar U, Aneja A, Lavie CJ, Deedwania P.

Curr Probl Cardiol. 2019 Jul;44(7):207-222. doi: 10.1016/j.cpcardiol.2018.06.004. Epub 2018 Jul 6. Review.

PMID:
30195639
16.

Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.

Lam PH, Gupta N, Dooley DJ, Singh S, Deedwania P, Zile MR, Bhatt DL, Morgan CJ, Pitt B, Fonarow GC, Ahmed A.

Am J Med. 2018 Dec;131(12):1473-1481. doi: 10.1016/j.amjmed.2018.07.008. Epub 2018 Aug 1.

PMID:
30076815
17.

Obesity is rarely healthy.

Lavie CJ, Deedwania P, Ortega FB.

Lancet Diabetes Endocrinol. 2018 Sep;6(9):678-679. doi: 10.1016/S2213-8587(18)30143-8. Epub 2018 May 31. No abstract available.

PMID:
29859910
18.

Dangers and Long-Term Outcomes in Metabolically Healthy Obesity: The Impact of the Missing Fitness Component.

Deedwania P, Lavie CJ.

J Am Coll Cardiol. 2018 May 1;71(17):1866-1868. doi: 10.1016/j.jacc.2018.02.057. No abstract available.

PMID:
29699612
19.

Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.

Tsimploulis A, Lam PH, Arundel C, Singh SN, Morgan CJ, Faselis C, Deedwania P, Butler J, Aronow WS, Yancy CW, Fonarow GC, Ahmed A.

JAMA Cardiol. 2018 Apr 1;3(4):288-297. doi: 10.1001/jamacardio.2017.5365. Erratum in: JAMA Cardiol. 2018 Apr 1;3(4):358.

20.

Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.

Deedwania P, Weber M, Reimitz PE, Bakris G.

J Clin Hypertens (Greenwich). 2017 Dec;19(12):1309-1318. doi: 10.1111/jch.13103. Epub 2017 Oct 25.

21.

Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.

Lam PH, Dooley DJ, Deedwania P, Singh SN, Bhatt DL, Morgan CJ, Butler J, Mohammed SF, Wu WC, Panjrath G, Zile MR, White M, Arundel C, Love TE, Blackman MR, Allman RM, Aronow WS, Anker SD, Fonarow GC, Ahmed A.

J Am Coll Cardiol. 2017 Oct 10;70(15):1861-1871. doi: 10.1016/j.jacc.2017.08.022.

22.

Hearty Breakfast for Healthier Arteries.

Deedwania P, Acharya T.

J Am Coll Cardiol. 2017 Oct 10;70(15):1843-1845. doi: 10.1016/j.jacc.2017.08.054. No abstract available.

23.

Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.

Lam PH, Dooley DJ, Fonarow GC, Butler J, Bhatt DL, Filippatos GS, Deedwania P, Forman DE, White M, Fletcher RD, Arundel C, Blackman MR, Adamopoulos C, Kanonidis IE, Aban IB, Patel K, Aronow WS, Allman RM, Anker SD, Pitt B, Ahmed A.

Eur J Heart Fail. 2018 Feb;20(2):359-369. doi: 10.1002/ejhf.937. Epub 2017 Oct 5.

24.

Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial.

Sabatine MS, Leiter LA, Wiviott SD, Giugliano RP, Deedwania P, De Ferrari GM, Murphy SA, Kuder JF, Gouni-Berthold I, Lewis BS, Handelsman Y, Pineda AL, Honarpour N, Keech AC, Sever PS, Pedersen TR.

Lancet Diabetes Endocrinol. 2017 Dec;5(12):941-950. doi: 10.1016/S2213-8587(17)30313-3. Epub 2017 Sep 15.

25.

Treatment of systolic hypertension and low diastolic blood pressure in older adults: How low is too low?!

Tsimploulis A, Sheriff HM, Anker MS, Deedwania P, Fletcher RD, Aronow WS, Anker SD, Ahmed A.

Int J Cardiol. 2017 Sep 1;242:21. doi: 10.1016/j.ijcard.2017.04.096. No abstract available.

PMID:
28619324
26.

Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.

Sheriff HM, Thogaripally MR, Panjrath G, Arundel C, Zeng Q, Fonarow GC, Butler J, Fletcher RD, Morgan C, Blackman MR, Deedwania P, Love TE, Aronow WS, Anker SD, Allman RM, Ahmed A.

J Am Med Dir Assoc. 2017 Sep 1;18(9):761-765. doi: 10.1016/j.jamda.2017.03.016. Epub 2017 May 11.

27.

Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16].

Tsimploulis A, Sheriff HM, Lam PH, Dooley DJ, Anker MS, Papademetriou V, Fletcher RD, Faselis C, Fonarow GC, Deedwania P, White M, Valentova M, Blackman MR, Banach M, Morgan CJ, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A.

Int J Cardiol. 2017 Jul 1;238:181. doi: 10.1016/j.ijcard.2017.04.072. Epub 2017 May 6. No abstract available.

PMID:
28487149
28.

Compliance with guideline-directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program.

Deedwania P, Acharya T, Kotak K, Fonarow GC, Cannon CP, Laskey WK, Peacock WF, Pan W, Bhatt DL; GWTG Steering Committee and Investigators.

Am Heart J. 2017 May;187:78-87. doi: 10.1016/j.ahj.2017.02.025. Epub 2017 Feb 23.

PMID:
28454811
29.

Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study.

Sheriff HM, Tsimploulis A, Valentova M, Anker MS, Deedwania P, Banach M, Morgan CJ, Blackman MR, Fonarow GC, White M, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A.

Int J Cardiol. 2017 Jul 1;238:140-143. doi: 10.1016/j.ijcard.2017.02.142. Epub 2017 Mar 1.

30.

Updated risk factors should be used to predict development of diabetes.

Bethel MA, Hyland KA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Levitt NS, McMurray JJV, Boutati E, Thomas L, Sun JL, Haffner SM; NAVIGATOR Study Group.

J Diabetes Complications. 2017 May;31(5):859-863. doi: 10.1016/j.jdiacomp.2017.02.012. Epub 2017 Mar 2.

PMID:
28319004
31.

Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.

Tsimploulis A, Sheriff HM, Lam PH, Dooley DJ, Anker MS, Papademetriou V, Fletcher RD, Faselis C, Fonarow GC, Deedwania P, White M, Valentova M, Blackman MR, Banach M, Morgan CJ, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A.

Int J Cardiol. 2017 May 15;235:11-16. doi: 10.1016/j.ijcard.2017.02.139. Epub 2017 Mar 1. Erratum in: Int J Cardiol. 2017 Jul 1;238:181.

32.

Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting?

Deedwania P, Acharya T.

J Am Coll Cardiol. 2017 Feb 21;69(7):786-788. doi: 10.1016/j.jacc.2016.11.062. No abstract available.

33.

Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.

Lam PH, Dooley DJ, Inampudi C, Arundel C, Fonarow GC, Butler J, Wu WC, Blackman MR, Anker MS, Deedwania P, White M, Prabhu SD, Morgan CJ, Love TE, Aronow WS, Allman RM, Ahmed A.

Int J Cardiol. 2017 Jan 15;227:462-466. doi: 10.1016/j.ijcard.2016.11.006. Epub 2016 Nov 4.

34.

Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.

Borer JS, Deedwania PC, Kim JB, Böhm M.

Am J Cardiol. 2016 Dec 15;118(12):1948-1953. doi: 10.1016/j.amjcard.2016.08.089. Epub 2016 Sep 15. Review.

PMID:
27780557
35.

Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.

Arundel C, Lam PH, Khosla R, Blackman MR, Fonarow GC, Morgan C, Zeng Q, Fletcher RD, Butler J, Wu WC, Deedwania P, Love TE, White M, Aronow WS, Anker SD, Allman RM, Ahmed A.

Am J Med. 2016 Nov;129(11):1178-1184. doi: 10.1016/j.amjmed.2016.06.018. Epub 2016 Jul 9.

36.

Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.

Srikanth S, Deedwania P.

Curr Hypertens Rep. 2016 Oct;18(10):76. Review.

PMID:
27730495
37.

Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.

Deedwania PC, Pedersen TR, DeMicco DA, Breazna A, Betteridge DJ, Hitman GA, Durrington P, Neil A; TNT, CARDS and IDEAL Steering Committees and Investigators.

Int J Cardiol. 2016 Nov 1;222:548-556. doi: 10.1016/j.ijcard.2016.07.201. Epub 2016 Jul 30.

PMID:
27513651
38.

Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.

Sanam K, Bhatia V, Bajaj NS, Gaba S, Morgan CJ, Fonarow GC, Butler J, Deedwania P, Prabhu SD, Wu WC, White M, Love TE, Aronow WS, Fletcher RD, Allman RM, Ahmed A.

Am J Med. 2016 Oct;129(10):1067-73. doi: 10.1016/j.amjmed.2016.05.008. Epub 2016 Jun 2.

39.

Mechanical Circulatory Support and Rationale for Future Research-Reply.

Deedwania P, Acharya T.

JAMA Intern Med. 2016 May 1;176(5):715-6. doi: 10.1001/jamainternmed.2016.0813. No abstract available.

PMID:
27136339
40.

Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study).

Shepherd J, Breazna A, Deedwania PC, LaRosa JC, Wenger NK, Messig M, Wilson DJ; Treating to New Targets Steering Committee and Investigators.

Am J Cardiol. 2016 Apr 15;117(8):1199-205. doi: 10.1016/j.amjcard.2016.01.014. Epub 2016 Jan 28.

41.

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.

Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, McKenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV, Underberg JA; NLA Expert Panel.

J Clin Lipidol. 2015 Nov-Dec;9(6 Suppl):S1-122.e1. doi: 10.1016/j.jacl.2015.09.002. Epub 2015 Sep 18. Erratum in: J Clin Lipidol. 2016 Jan-Feb;10(1):211. Underberg, James A [added].

42.

Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.

Deedwania PC, Stone PH, Fayyad RS, Laskey RE, Wilson DJ.

Drugs Aging. 2015 Dec;32(12):1055-65. doi: 10.1007/s40266-015-0328-z.

43.

Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation.

Acharya T, Tringali S, Bhullar M, Nalbandyan M, Ilineni VK, Carbajal E, Deedwania P.

Am J Cardiol. 2015 Dec 15;116(12):1852-7. doi: 10.1016/j.amjcard.2015.09.025. Epub 2015 Oct 3.

PMID:
26611122
44.

Is Increased Use of Mechanical Circulatory Support Devices Justified? A Cause for Concern.

Deedwania P, Acharya T.

JAMA Intern Med. 2015 Dec;175(12):1982-3. doi: 10.1001/jamainternmed.2015.6093. No abstract available.

PMID:
26523417
45.

The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?

Kiel RG, Deedwania P.

Expert Opin Drug Saf. 2015;14(12):1855-63. doi: 10.1517/14740338.2015.1102225. Epub 2015 Oct 21. Review.

PMID:
26488593
46.

Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.

Deedwania PC, Shepherd J, Breazna A, DeMicco DA; Treating to New Targets (TNT) Steering Committee Investigators.

Diabetes Obes Metab. 2016 Jan;18(1):56-63. doi: 10.1111/dom.12581.

PMID:
26434404
47.

Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology.

Morris PB, Ference BA, Jahangir E, Feldman DN, Ryan JJ, Bahrami H, El-Chami MF, Bhakta S, Winchester DE, Al-Mallah MH, Sanchez Shields M, Deedwania P, Mehta LS, Phan BA, Benowitz NL.

J Am Coll Cardiol. 2015 Sep 22;66(12):1378-91. doi: 10.1016/j.jacc.2015.07.037. Review.

48.

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research; American Diabetes Association.

Diabetes Care. 2015 Sep;38(9):1777-803. doi: 10.2337/dci15-0012. Epub 2015 Aug 5. Review.

49.

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association.

Circulation. 2015 Aug 25;132(8):691-718. doi: 10.1161/CIR.0000000000000230. Epub 2015 Aug 5. Review.

PMID:
26246173
50.

Management of Patients With Stable Angina and Type 2 Diabetes.

Deedwania PC.

Rev Cardiovasc Med. 2015;16(2):105-13. Review.

PMID:
26198557

Supplemental Content

Loading ...
Support Center